Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Schizophrenia Excellence Forum

Schizophrenia
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Podcasts
How TAAR1 Agonists Might Be Used in Schizophrenia Treatment, With Dr Leslie Citrome
08/02/2022
In this podcast, Psych Congress Network's Schizophrenia Section Editor Leslie L. Citrome, MD, MPH, answers questions about the potential uses of TAAR1 agonists in the treatment of schizophrenia. Andrew Penn, MS, PMHNP, moderates.
In this podcast, Psych Congress Network's Schizophrenia Section Editor Leslie L. Citrome, MD, MPH, answers questions about the potential uses of TAAR1 agonists in the treatment of schizophrenia. Andrew Penn, MS, PMHNP, moderates.
In this podcast, Psych Congress...
08/02/2022
Psych Congress Network
Dr Jonathan M. Meyer.
Videos
Tailoring Treatment to Patient Goals and Providing the Clozapine Option as Standard of Care With Dr Jonathan M. Meyer
07/18/2022
Jonathan M. Meyer, MD, provides insights on how to prioritize patients' goals for treatment and the importance of offering clozapine as an option to treatment resistant patients.
Jonathan M. Meyer, MD, provides insights on how to prioritize patients' goals for treatment and the importance of offering clozapine as an option to treatment resistant patients.
Jonathan M. Meyer, MD, provides...
07/18/2022
Psych Congress Network
Dr Jonathan M Meyer
Videos
Making Space for Patient Needs When Treating First-Episode Schizophrenia With Dr Jonathan M. Meyer
07/14/2022
Jonathan Meyer, MD, explains how to account for each patient's unique needs and concerns, frame the benefit of medications around patient goals, and bring up long-acting injectables (LAIs).
Jonathan Meyer, MD, explains how to account for each patient's unique needs and concerns, frame the benefit of medications around patient goals, and bring up long-acting injectables (LAIs).
Jonathan Meyer, MD, explains...
07/14/2022
Psych Congress Network
Ilan Melnick, MD.
Videos
Intervening Early With Long-Acting Injectables
07/05/2022
In this video, Psych Congress Steering Committee member Ilan Melnick, MD, explains the benefits of early patient intervention using long-acting injectables (LAIs) to achieve stability and treatment adherence.
In this video, Psych Congress Steering Committee member Ilan Melnick, MD, explains the benefits of early patient intervention using long-acting injectables (LAIs) to achieve stability and treatment adherence.
In this video, Psych Congress...
07/05/2022
Psych Congress Network
Rebecca Kraus.
Videos
Overcoming Schizophrenia Treatment Challenges and the Potential of TAAR1
06/22/2022
Rebecca Kraus, MSPS, PA-C, explains common treatment challenges that clinicians encounter when treating patients with schizophrenia, barriers to accessing treatment, and the exciting potential of trace amine-associated receptor (TAAR1)...
Rebecca Kraus, MSPS, PA-C, explains common treatment challenges that clinicians encounter when treating patients with schizophrenia, barriers to accessing treatment, and the exciting potential of trace amine-associated receptor (TAAR1)...
Rebecca Kraus, MSPS, PA-C,...
06/22/2022
Psych Congress Network
Craig Chepke and Leslie Citrome
Podcasts
Schizophrenia Treatment Questions Answered: Autoinjectors for LAIs, Utlizing Olanzapine Pamoate
06/17/2022
Using autoinjectors for LAIs can empower both the provider and the patient, Craig Chepke, MD, FAPA. Also, Leslie Citrome, MD, MPH, discusses his experience with olanzapine pamoate.
Using autoinjectors for LAIs can empower both the provider and the patient, Craig Chepke, MD, FAPA. Also, Leslie Citrome, MD, MPH, discusses his experience with olanzapine pamoate.
Using autoinjectors for LAIs can...
06/17/2022
Psych Congress Network
Dr Citrome and Dr Chepke
Podcasts
Demystifying Schizophrenia Treatment: Comparing Medications and Explaining LAIs to Patients
06/14/2022
The difference between risperidone and paliperidone, choosing between risperidone and aripiprazole, and demystifying needles with patients to make them more comfortable during treatment with LAIs.
The difference between risperidone and paliperidone, choosing between risperidone and aripiprazole, and demystifying needles with patients to make them more comfortable during treatment with LAIs.
The difference between...
06/14/2022
Psych Congress Network
citrome and chepke
Podcasts
LAI Antipsychotics are Not a "Last Resort" Says Drs Citrome and Chepke
06/07/2022
Long-acting injectable antipsychotics (LAIs) allow patients with schizophrenia to take control of their illness and should be utilized earlier in the treatment algorithm, said Craig Chepke, MD, FAPA, and Leslie Citrome, MD, MPH.
Long-acting injectable antipsychotics (LAIs) allow patients with schizophrenia to take control of their illness and should be utilized earlier in the treatment algorithm, said Craig Chepke, MD, FAPA, and Leslie Citrome, MD, MPH.
Long-acting injectable...
06/07/2022
Psych Congress Network
Lindsay Galvin Rauch
Videos
Education for Clinicians, Family, and Law Enforcement is Key in Better Treatment of Schizophrenia, Says Advocate
12/20/2021
Sibling of 6 brothers diagnosed with schizophrenia, says clinicians, families, and law enforcement could benefit from education about the disorder, specifically the comorbid condition of anosognosia.
Sibling of 6 brothers diagnosed with schizophrenia, says clinicians, families, and law enforcement could benefit from education about the disorder, specifically the comorbid condition of anosognosia.
Sibling of 6 brothers diagnosed...
12/20/2021
Psych Congress Network
Lindsay Galvin Rauch
Videos
Anosognosia Education Could Help Clinicians Treat Schizophrenia More Effectively
12/15/2021
Anosognosia affects a large percentage of patients with schizophrenia and knowledge of it can help clinicians and caretakers better treat patients, says Linsday Galvin Rauch in part 5 of this series.
Anosognosia affects a large percentage of patients with schizophrenia and knowledge of it can help clinicians and caretakers better treat patients, says Linsday Galvin Rauch in part 5 of this series.
Anosognosia affects a large...
12/15/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement